您的账号已在其他设备登录,您当前账号已强迫下线,
如非您本人操作,建议您在会员中心进行密码修改

确定
收藏 | 浏览203 | 下载161

In recent years,researchers have found that CD26 (dipeptidyl peptidase 4) is closely related to the formation and development of many fibrotic diseases.Hypertrophic scar,keloid,and other skin fibrosis diseases are major problems nowadays,which may affect the patient's appearance and cause joints deformity and dysfunction due to scar contracture.This article briefly reviews the relationship between CD26 and hypertrophic scar and keloid to provide new insights into the treatment of skin fibrotic diseases.

作者:宋晨璐;姚敏

来源:中华烧伤杂志 2018 年 34卷 1期

知识库介绍

临床诊疗知识库该平台旨在解决临床医护人员在学习、工作中对医学信息的需求,方便快速、便捷的获取实用的医学信息,辅助临床决策参考。该库包含疾病、药品、检查、指南规范、病例文献及循证文献等多种丰富权威的临床资源。

详细介绍
热门关注
免责声明:本知识库提供的有关内容等信息仅供学习参考,不代替医生的诊断和医嘱。

收藏
| 浏览:203 | 下载:161
作者:
宋晨璐;姚敏
来源:
中华烧伤杂志 2018 年 34卷 1期
标签:
二肽基肽酶4 瘢痕疙瘩 纤维化 CD26 增生性瘢痕 Dipeptidyl peptidase 4 Keloid Fibrosis CD26 Hypertrophic scar
In recent years,researchers have found that CD26 (dipeptidyl peptidase 4) is closely related to the formation and development of many fibrotic diseases.Hypertrophic scar,keloid,and other skin fibrosis diseases are major problems nowadays,which may affect the patient's appearance and cause joints deformity and dysfunction due to scar contracture.This article briefly reviews the relationship between CD26 and hypertrophic scar and keloid to provide new insights into the treatment of skin fibrotic diseases.